These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7349691)
1. [Our experience with dapsone in dermatology]. Rollier R LARC Med; 1981 Dec; 1(3):65-6. PubMed ID: 7349691 [No Abstract] [Full Text] [Related]
2. [Indications for sulfones in dermatology (excluding leprosy). Experience of the dermatological clinic in Strasbourg]. Samsoen M; Bousquet F; Basset A LARC Med; 1981 Dec; 1(3):63-4. PubMed ID: 7349690 [No Abstract] [Full Text] [Related]
3. [Dapsone in skin diseases]. Zalewska A; Napieralska-Krzysiek E Pol Merkur Lekarski; 2003 Nov; 15(89):484-6. PubMed ID: 14969150 [TBL] [Abstract][Full Text] [Related]
4. Dapsone and sulfones in dermatology: overview and update. Zhu YI; Stiller MJ J Am Acad Dermatol; 2001 Sep; 45(3):420-34. PubMed ID: 11511841 [TBL] [Abstract][Full Text] [Related]
6. Fatal thrombocytopenic hemorrhagic diathesis associated with dapsone administration to a dog. Lees GE; McKeever PJ; Ruth GR J Am Vet Med Assoc; 1979 Jul; 175(1):49-52. PubMed ID: 574135 [TBL] [Abstract][Full Text] [Related]
7. Dapsone and sulfones in dermatology: overview and update. Pfeiffer C; Wozel G J Am Acad Dermatol; 2003 Feb; 48(2):308-9. PubMed ID: 12582416 [No Abstract] [Full Text] [Related]
20. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]